Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome

Affiliations

• ¹ The Leslie and Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, 5290002, Ramat-Gan, Israel.
• ² The Paul Feder Laboratory On Alzheimer's Disease Research, Bar-Ilan University, 5290002, Ramat-Gan, Israel.
• ³ Laboratory of Molecular Biology and Immunology, NIA, Baltimore, MD, 21224, USA.
• ⁴ Cancer Genomics and BioComputing of Complex Diseases Lab, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
• ⁵ Leumit Health Services, Department of Family Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.
• ⁶ Sant Pau Memory Unit, Department of Neurology, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
• ⁷ Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
• ⁸ Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
• ⁹ Alzheimer-Down Unit, Fundación Catalana Síndrome de Down, Barcelona, Spain.
• ¹⁰ Department of Anatomy and Cell Biology, McGill University, Montreal, Canada.
• ¹¹ Center for Genomic Regulation, The Barcelona Institute for Science and Technology, Barcelona, Spain.
• ¹² University Pompeu Fabra, Barcelona, Spain.
• ¹³ Biomedical Research Networking Center for Rare Diseases (CIBERER), Barcelona, Spain.
• ¹⁴ Cellular & Systems Neurobiology, Systems Biology Program, The Barcelona Institute of Science and Technology, Centre for Genomic Regulation (CRG), Dr. Aiguader 88, 08003, Barcelona, Spain.
• ¹⁵ Universitat Pompeu Fabra (UPF), Barcelona, Spain.
• ¹⁶ Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
• ¹⁷ School of Education, Bar-Ilan University, 5290002, Ramat-Gan, Israel.
• ¹⁸ Department of Genetic Medicine and Development, University of Geneva, 1211, Geneva, Switzerland.
• ¹⁹ Medigenome, Swiss Institute of Genomic Medicine, 1207, Geneva, Switzerland.
• ²⁰ iGE3 Institute of Genetics and Genomics of Geneva, 1211, Geneva, Switzerland.
• ²¹ The Children's Guild Foundation Down Syndrome Research Program, Genetics and Genomics Program and Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• ²² Genetics, Genomics and Bioinformatics Program, State University of New York At Buffalo, Buffalo, NY, USA.
• ²³ Université de Strasbourg, CNRS, INSERM, Institut de Génétique Biologie Moléculaire Et Cellulaire, IGBMC-UMR, 7104 - Inserm U1258, 1 rue Laurent Fries, ILLKIRCH, 67404, Cedex, France.
• ²⁴ Paris Brain Institute (ICM), CNRS UMR7225, INSERM U1127, Sorbonne Université, Hôpital de La Pitié-Salpêtrière, Paris, France.
• ²⁵ Department of Biology, Indiana University-Purdue University Indianapolis, Indianapolis, USA.
• ²⁶ The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, 5290002, Ramat-Gan, Israel.
• ²⁷ Université de Paris, BFA, UMR 8251, CNRS, 7501, Paris, France.
• ²⁸ Department of Neurosciences, University of California, San Diego, USA.
• ²⁹ Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.
• ³⁰ South London and Maudsley NHS Foundation Trust, London, UK.
• ³¹ The Leslie and Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, 5290002, Ramat-Gan, Israel. eitan.okun@biu.ac.il.
• ³² The Paul Feder Laboratory On Alzheimer's Disease Research, Bar-Ilan University, 5290002, Ramat-Gan, Israel. eitan.okun@biu.ac.il.
• ³³ The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, 5290002, Ramat-Gan, Israel. eitan.okun@biu.ac.il.